证券之星消息，1月28日化学制品板块较上一交易日上涨1.38%，锦鸡股份领涨。当日上证指数报收于 4151.24，上涨0.27%。深证成指报收于14342.9，上涨0.09%。化学制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300798 | 锦鸡股份 | 9.58 | 20.05% | 81.59万 | | 7.45 Z | | 002440 | 国王股份 | 10.75 | 10.03% | 68.71万 | | 7.35亿 | | 600230 | 沧州大化 | 20.78 | 10.01% | 28.30万 | | 5.66亿 | | 600352 | 浙江龙盛 | 14.75 | 9.99% | 92.85万 | | 13.62亿 | | 002455 | 直川股份 | 7.93 | 9.99% | 63.07万 | | 4.98 亿 | | 603188 | 亚邦股份 | 5.31 | 9.94% | 25.29万 | | 1.33亿 | ...

Group 1 - The company announced that it has applied for a comprehensive credit limit of 100 million yuan from China Merchants Bank, with the credit period from January 27, 2026, to January 26, 2027 [1] - The wholly-owned subsidiary, Daierke, provides a joint liability guarantee for this credit limit and has signed an "Irrevocable Maximum Guarantee Agreement," which has been approved through Daierke's internal procedures [1] - As of the announcement date, the total external guarantees provided by the company amount to 46 million yuan, accounting for 1.31% of the most recent audited net assets, with no overdue external guarantees [1]

Core Viewpoint - The company, Jiu Ri New Materials, has indicated that approximately 12% of its total revenue comes from exports to the European Union, highlighting the significance of this market for its business operations [1] Group 1: Revenue Contribution - The revenue from the European market accounts for about 12% of the company's overall operating income [1] Group 2: Sales Strategy - The company has established an office in Europe and primarily conducts sales in this region through direct sales [1]

格隆汇1月28日｜有投资者在互动平台向久日新材提问：欧盟国家为公司光引发剂产品的主要出口地 区。请问欧盟地区业务收入在公司整体营业收入中的占比大致为多少？此外，公司对欧盟市场的销售主 要通过哪种方式实现：是以境内主体直接向欧盟客户出口为主，还是通过在欧盟国家设立的子公司进行 销售，或通过第三方贸易商、代理商转销至欧盟市场？ 久日新材回复称，公司对欧洲的出口金额约占公司营业收入的12%左右。公司在欧洲设有办事处，对欧 洲市场的销售主要通过直销方式实现。 ...

Group 1 - Precious metals and non-ferrous metals have surged again, with the A500 ETF (512050) rising by 0.40% as of 13:43, benefiting from strong performance in key sectors [1] - The A500 ETF has seen a year-to-date increase of over 33% as of yesterday, indicating robust market performance [1] - The Chinese yuan's central parity rate against the US dollar was adjusted up by 103 points to 6.9755, the highest since May 2023, with the largest increase since August [1] Group 2 - The A500 ETF (512050) offers investors a way to access core A-share assets with a low fee rate of only 0.2%, high liquidity, and a scale exceeding 40 billion yuan [2] - The ETF tracks the CSI A500 Index, employing a dual strategy of industry-balanced allocation and leading stock selection, covering all 35 sub-sectors [2] - Compared to the CSI 300, the A500 ETF is overweight in sectors such as AI industry chain, pharmaceutical biology, and new energy power equipment, showcasing a natural "barbell" investment strategy [2]

智通财经APP讯，新宙邦(300037.SZ)发布公告，公司已于2026年1月27日向香港联合交易所有限公司(以 下简称"香港联交所")递交了发行境外上市外资股(H股)股票并在香港联交所主板挂牌上市的申请，并于 同日在香港联交所网站刊登了本次发行上市的申请资料。 ...

Group 1 - Puyang Huicheng's stock increased by 5.16% to 18.53 CNY per share, with a trading volume of 194 million CNY and a turnover rate of 3.72%, resulting in a total market capitalization of 5.408 billion CNY [1] - Puyang Huicheng Electronic Materials Co., Ltd. is located in Puyang City, Henan Province, established on December 27, 2002, and listed on June 30, 2015. The company's main business includes the research, production, and sales of fine chemicals such as anhydride derivatives and functional material intermediates [1] - The revenue composition of Puyang Huicheng is as follows: anhydride derivatives account for 80.54%, functional material intermediates 19.29%, and others 0.17% [1] Group 2 - Southern Fund's Southern Baoyuan Bond A (202101) is among the top ten circulating shareholders of Puyang Huicheng, holding 1.3001 million shares, unchanged from the previous period, representing 0.45% of circulating shares, with an estimated floating profit of approximately 1.183 million CNY [2] - Southern Baoyuan Bond A (202101) was established on September 20, 2002, with a latest scale of 6.212 billion CNY. Year-to-date return is 2.87%, ranking 347 out of 7083 in its category; the one-year return is 10.57%, ranking 327 out of 6282; and since inception, the return is 726.74% [2] Group 3 - The fund managers of Southern Baoyuan Bond A (202101) are Lin Lefeng and Liu Yicheng. Lin Lefeng has a tenure of 9 years and 307 days, managing a total fund size of 17.61 billion CNY, with the best return during his tenure being 177.15% and the worst 5.08% [3] - Liu Yicheng has a tenure of 3 years and 334 days, managing a total fund size of 16.872 billion CNY, with the best return during his tenure being 25.83% and the worst 0.76% [3]

Summary of Lianhua Technology Conference Call Company Overview - **Company**: Lianhua Technology - **Industry**: Chemical manufacturing, focusing on agricultural protection, pharmaceutical raw materials, and functional chemicals Key Points Financial Performance - **Q4 2024 Performance**: Expected non-net profit growth of 172% to 238%, driven by increased capacity utilization, exchange rate gains, and business improvements [2][3] - **2025 Profit Forecast**: Projected net profit of 350 million to 420 million CNY, representing a year-on-year increase of 239% to 307% [3] Business Segments - **Agricultural Protection**: Accounts for approximately 60% of revenue, significantly influenced by market cycles. The company collaborates with major global agricultural firms and has a diversified base layout to mitigate risks [2][4][8] - **Pharmaceuticals**: The CDMO segment has shown steady growth, contributing significantly to profits. The company has 18 commercialized products and multiple clinical-stage products, with a focus on maintaining strong client relationships and quality management [2][9][11] - **New Energy**: Focuses on battery-related chemicals, including lithium hexafluorophosphate (LiFSI), with planned capacities of 20,000 tons for lithium hexafluorophosphate and 10,000 tons for LiFSI. This segment is viewed as a long-term growth area despite current challenges [2][12][17] - **Equipment and Engineering Services**: Managed by Shanghai Baofeng, this segment provides stable revenue through sales of energy-saving equipment and chemical containers, serving clients in various industries [2][13] Strategic Developments - **Global Base Distribution**: The company operates 9 bases globally, with 7 in China and 2 overseas in the UK and Malaysia. The UK base has recently turned profitable after adjustments, while the Malaysian base is under construction and expected to enhance order volume [6][14] - **R&D Investment**: Maintains a research and development expense ratio of approximately 5%, which is above the industry average. The company has developed various synthesis technologies that strengthen its CDMO capabilities [7] Market Trends and Competitive Position - **Agricultural Market Trends**: Currently in a recovery phase, with Lianhua Technology positioned as a leading domestic CDMO player due to long-term partnerships with major global firms [8] - **Pharmaceutical CDMO Growth**: This segment is less cyclical than agricultural protection, indicating greater growth potential. The company has established strong ties with top pharmaceutical companies [9][16] Future Outlook - **Long-term Growth Potential**: Expected profits of approximately 409 million CNY in 2025, 581 million CNY in 2026, and 727 million CNY in 2027, indicating a positive long-term outlook [20] - **Focus Areas**: 1. Agricultural protection business growth through the Malaysian base 2. Expansion of pharmaceutical CDMO projects to enhance client retention 3. Anticipated sales growth in the new energy materials sector post-technical upgrades [21][22] Challenges and Historical Context - **Past Challenges**: The company faced significant operational challenges due to environmental regulations and incidents, particularly affecting the UK base. Recovery has been gradual, with improvements expected in profitability [18] Industry Context - **CDMO Industry Dynamics**: The CDMO sector is characterized by outsourcing supply chains to reduce costs and ensure compliance. Chinese companies have unique advantages in human resources and problem-solving capabilities, allowing them to thrive despite competition [19]

Group 1 - The company, Guanghua Technology, is actively monitoring the cutting-edge developments in industry technology [1]

证券日报网讯1月27日，雅化集团（002497）发布公告称，公司预计2025年度归属于上市公司股东的净 利润为60，000万元至68，000万元，比上年同期增长133.36%至164.47%。 ...